[HTML][HTML] CAR-cell therapy in the era of solid tumor treatment: current challenges and emerging therapeutic advances

KM Maalej, M Merhi, VP Inchakalody, S Mestiri… - Molecular Cancer, 2023 - Springer
In the last decade, Chimeric Antigen Receptor (CAR)-T cell therapy has emerged as a
promising immunotherapeutic approach to fight cancers. This approach consists of …

[HTML][HTML] CAR-NK cells: A promising cellular immunotherapy for cancer

G Xie, H Dong, Y Liang, JD Ham, R Rizwan, J Chen - EBioMedicine, 2020 - thelancet.com
Natural Killer (NK) cells and CD8+ cytotoxic T cells are two types of immune cells that can
kill target cells through similar cytotoxic mechanisms. With the remarkable success of …

[HTML][HTML] Natural killer cells: a promising immunotherapy for cancer

J Chu, F Gao, M Yan, S Zhao, Z Yan, B Shi… - Journal of translational …, 2022 - Springer
As a promising alternative platform for cellular immunotherapy, natural killer cells (NK) have
recently gained attention as an important type of innate immune regulatory cell. NK cells can …

[HTML][HTML] NK cell-based immune checkpoint inhibition

M Khan, S Arooj, H Wang - Frontiers in immunology, 2020 - frontiersin.org
Immunotherapy, with an increasing number of therapeutic dimensions, is becoming an
important mode of treatment for cancer patients. The inhibition of immune checkpoints …

Mild magnetic hyperthermia-activated innate immunity for liver cancer therapy

J Pan, Y Xu, Q Wu, P Hu, J Shi - Journal of the American Chemical …, 2021 - ACS Publications
Magnetic hyperthermia therapy (MHT) is noninvasive and features excellent tissue
penetration for deep-seated tumors, but unfortunately, it suffers the low therapeutic efficacy …

[HTML][HTML] Aging of the immune system: focus on natural killer cells phenotype and functions

A Brauning, M Rae, G Zhu, E Fulton, TD Admasu… - Cells, 2022 - mdpi.com
Aging is the greatest risk factor for nearly all major chronic diseases, including
cardiovascular diseases, cancer, Alzheimer's and other neurodegenerative diseases of …

[HTML][HTML] Tumor microenvironment of hepatocellular carcinoma: challenges and opportunities for new treatment options

Z Sas, E Cendrowicz, I Weinhäuser… - International Journal of …, 2022 - mdpi.com
The prevalence of liver cancer is constantly rising, with increasing incidence and mortality in
Europe and the USA in recent decades. Among the different subtypes of liver cancers …

[HTML][HTML] Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer

R Zhang, F Qi, F Zhao, G Li, S Shao, X Zhang… - Cell death & …, 2019 - nature.com
Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs) are
important components of the tumor microenvironment, which have been reported to localize …

[HTML][HTML] HBV-induced immune imbalance in the development of HCC

Y Chen, Z Tian - Frontiers in immunology, 2019 - frontiersin.org
Chronic hepatitis B virus (HBV) infection is one of the high-risk factors for human HCC.
Despite the integration of virus DNA and the oncoprotein HBx, chronic necroinflammation …

[PDF][PDF] Intrahepatic cholangiocarcinoma: continuing challenges and translational advances

AE Sirica, GJ Gores, JD Groopman, FM Selaru… - …, 2019 - Wiley Online Library
Intrahepatic cholangiocarcinoma (iCCA) has over the last 10‐20 years become the focus of
increasing concern, largely due to its rising incidence and high mortality rates worldwide …